Medicinal Chemistry of Anticancer Drugs (Record no. 15804)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01882nam a2200181Ia 4500 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 140223b2008 xxu||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9780444528247 |
| Terms of availability | 0.00 |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 615.19 |
| Item number | AVE |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Avendano, Carmen |
| 9 (RLIN) | 19240 |
| 245 ## - TITLE STATEMENT | |
| Title | Medicinal Chemistry of Anticancer Drugs |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication, distribution, etc | Amsterdam |
| Name of publisher, distributor, etc | Elsevier |
| Date of publication, distribution, etc | 2008 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 442p |
| 500 ## - GENERAL NOTE | |
| General note | Antitumour chemotherapy is nowadays a very active field of research, and a huge amount of information on the topic is generated every year. Although many books are available that deal with clinical aspects of cancer chemotherapy, this book addresses the need for an updated treatment from the point of view of medicinal chemistry and drug design. Cytotoxic chemotherapy is gradually being supplemented by a new generation of drugs that recognize specific targets on the surface or inside cancer cells. These therapies are in their infancy, but they hold promise of more effective therapies with fewer side effects. Resistance to antitumour drugs is another important but normally neglected field. The focus of Medicinal Chemistry of Anticancer Drugs is on the mechanism of action of antitumour drugs from the molecular point of view and on the relationship between chemical structure and chemical and biochemical reactivity of antitumour agents, aiming at the rationalization of the action of this type of drugs, which would allow the design of new active structures.Presents information in a clear and concise way using a large number of figures. Historical background provides insights on how the process of drug discovery in the anticancer field has evolved.Extensive references to primary literature . |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
| Personal name | Medicinal Chemistry |
| 9 (RLIN) | 19241 |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Menendez, J. Carlos |
| 9 (RLIN) | 19242 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | Dewey Decimal Classification |
| Item type | Book |
| Call number prefix | 615.19 |
| Call number suffix | AVE |
| 995 ## - RECOMMENDATION 995 [LOCAL, UNIMARC FRANCE] | |
| Origin of item (home branch) (free text) | Pharmacy Reference |
| Genre | P0006041 |
| Section | 615.19 |
| Recipient parent organisation code | P0006041 |
No items available.